Zanzibar. The Zanzibar Food, Drugs and Cosmetics Agency (ZFDA) has withdrawn a batch of PED Zinc (Zinc Sulphate Dispersible Tablet) from the market due to quality concerns.
The affected batch, numbered 2203002, was manufactured by Beta Healthcare International Ltd, based in Nairobi, Kenya.
A statement issued yesterday and signed by ZFDA’s Executive Director, Dr Burhan Othman Simai, confirmed that health centres had raised complaints about the tablets producing a cloudy residue.
According to the statement, the affected batch was produced on 1 March, 2022, with the expiry date of 28 February, 2025.
“Following the complaints, ZFDA conducted an investigation, including laboratory analysis of samples. The results confirmed that the batch failed quality tests, rendering it unsuitable for human consumption,” Dr Simai stated.
He urged the public to identify and avoid using the recalled medication. Those already in possession of the affected batch are advised to return it to their respective health centres or the pharmacies where they obtained it.
Additionally, health professionals have been instructed to discontinue dispensing the affected tablets, separate them from their inventory, and return them to their suppliers.
ZFDA has also ordered importers, distributors, and both wholesalers and retailers to halt the distribution and sale of the recalled batch. Instead, they are required to isolate the stock and hand it over to ZFDA for proper disposal.
“ZFDA urges healthcare professionals and the public to continue reporting any pharmaceutical products suspected of poor quality or adverse effects. This will enable timely interventions to safeguard public health,” the statement added.
In May 2024, ZFDA also withdrew over 1,000 tins of Infacare infant formula from the market and imposed a ban on its importation, sale, and distribution. The decision was made after it was discovered that the product contained labels indicating it was ‘not for sale in Tanzania.’
However, the agency revealed that some traders had engaged in fraudulent practices by removing the original labels, covering them with stickers, or replacing the original lids to bypass the restriction. ZFDA warned that such acts are illegal.
The recall was enforced because the product did not meet the regulatory requirements for food safety, registration, and quality assurance. During inspections, ZFDA confiscated over 1,000 tins of the formula that were found with the prohibited markings.
ZFDA continues to monitor the market to ensure compliance with safety standards and urges the public to remain vigilant when purchasing pharmaceutical and food products.
Share this news
This Year's Most Read News Stories
Tanzania Declares Marburg Outbreak – Africa CDC Mobilizes Immediate Response
Addis Ababa, January 20, 2025</Strong> — Tanzania has declared a Marburg virus disease (MVD) outbreak after confirming one case and identifying 25 suspected cases in the Kagera Region of Northwestern Tanzania. The Marburg virus, a highly infectious and often fatal disease, is similar to Ebola and is transmitted to humans from fruit bats and monkeys. This outbreak marks the nation’s second encounter with the deadly virus, following the outbreak in Bukoba District of Kagera Region in March 2023, which resulted in nine cases and six deaths.
In response to this urgent threat, the Africa CDC is mobilizing strong support to help Tanzania contain the outbreak. A team of twelve public health experts will be deployed as part of an advance mission in the next 24 hours. The multidisciplinary team includes epidemiologists, risk communication, infection prevention and control (IPC), and laboratory experts to provide on-ground support for surveillance, IPC, diagnostics, and community engagement.
The Director-General of Africa CDC, Dr. Jean Kaseya, has engaged with Tanzania’s President Samia Suluhu Hassan and the Minister of Health to ensure coordinated efforts and secure political commitment for the response.
“Africa CDC stands firmly with Tanzania in this critical moment. To support the government’s efforts, we are committing US$ 2 million to bolster immediate response measures, including deploying public health experts, strengthening diagnostics, and enhancing case management. Building on Tanzania’s commendable response during the 2023 outbreak, we are confident that swift and decisive action, combined with our support and those of other partners, will bring this outbreak under control,” Dr. Kaseya stated.
Africa CDC has recently supported efforts to enhance the diagnostic and sequencing capacity of public health laboratories in Tanzania. PCR Test kits and genomic sequencing reagents have been dispatched, with additional supplies in the pipeline. To ensure rapid identification and confirmation of cases, the institution will also provide technical assistance to strengthen detection and genome sequencing for better characterization of the pathogen. Additionally, support will be provided to improve case management protocols and enhance the capacity to deliver safe and effective treatment.
Africa CDC is committed to working closely with the Government of Tanzania, regional partners, international organizations, and global stakeholders, including the World Health Organization, to stop the spread of the Marburg virus.
Source: allafrica.com
For years, a UK mining giant was untouchable in Zambia for pollution until a former miner’s son took them on
For years, the people in the villages around Chingola in Zambia endured frequent health challenges and dead fish floating around in their water source, but that was just the beginning of their nightmare.Continue Reading
British Investor’s $1.6 billion real estate project in Zanzibar lies in limbo
The revocation of British developer Pennyroyal’s leasehold for the construction of Blue Amber Resort by the Revolutionary Government of Zanzibar has sent shock waves in the nascent property market on the Isles.Continue Reading
